CAS 1855006-12-0

Fórmula: C20H18FN5O3

InChI: InChI=1S/C20H18FN5O3/c1-22-19(27)17-9-12(5-7-24-17)26-16-4-3-13(10-15(16)21)29-14-6-8-25-18(11-14)20(28)23-2/h3-11H,1-2H3,(H,22,27)(H,23,28)(H,24,26)

Clave InChI: USLJNRHZMUHXEP-UHFFFAOYSA-N

SMILES: CNC(=O)C1=NC=CC(=C1)NC2=C(C=C(C=C2)OC3=CC(=NC=C3)C(=O)NC)F

Regorafenib Dipyrimidine

CAS: 1855006-12-0

Pureza: 98%

Ref: IN-DA01WZKV

Regorafenib EP Impurity C

CAS: 1855006-12-0

Fórmula: C₂₀H₁₈FN₅O₃

Forma y color: Pale Yellow Solid

Peso molecular: 395.39

Ref: 4Z-R-078014

Regorafenib Dipyrimidine

Producto controlado

CAS: 1855006-12-0

Fórmula: C₂₀H₁₈FN₅O₃

Forma y color: Neat

Peso molecular: 395.387

Ref: TR-R143355

4-(3-Fluoro-4-((2-(methylcarbamoyl)pyridin-4-yl)amino)phenoxy)-N-methylpicolinamide

Producto controlado

CAS: 1855006-12-0

Fórmula: C₂₀H₁₈FN₅O₃

Forma y color: Neat

Peso molecular: 395.39

Ref: TR-F593180

Regorafenib dipyrimidine

CAS: 1855006-12-0

Regorafenib dipyrimidine is a small molecule with a unique chemical structure that inhibits the activity of multiple receptors and ion channels, such as the epidermal growth factor receptor (EGFR) and potassium channels. The antibody is used to study protein interactions, cell biology, pharmacology, and research tools. It is also used as a reagent for binding peptides and ligands for activation studies. Regorafenib dipyrimidine has been shown to have an inhibitory effect on EGFR-mediated signal transduction pathways in vitro and in vivo. The compound also inhibits proliferation of tumor cells in vitro and reduces tumor burden in vivo.

Fórmula: C₂₀H₁₈FN₅O₃

Pureza: Min. 95%

Peso molecular: 395.4 g/mol

Ref: 3D-FZC00612

Regorafenib EP Impurity C

CAS: 1855006-12-0

Fórmula: C₂₀H₁₈FN₅O₃

Peso molecular: 395.39

Ref: ST-EA-CP-R59003